ERBB2 and breast cancer: Most notably, genetic alterations were found to be higher in normal breast tissues (11/36, 30.56%) than LumA (101/499, 20.24%), LumB (38/197, 19.29%), and HER2 (23/76, 29.49%) subtypes of breast cancer (Figure 8C).